Parkinson Disease: all 4,583 studies

Page 14 of 46. Open to participants first (1,097), then studies with results posted, then the rest; newest registration first within each.

• Effectiveness of Botox on Reducing Rest Tremor in Parkinson's DiseaseCompletedNCT03301272Phase 2Results posted
• A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by "OFF" EpisodesCompletedNCT03292016Phase 2Results posted
• Effects of Neuromodulation and Rehabilitation of the Locomotor Network in Freezing of GaitCompletedNCT03273270Not applicableResults posted
• Scalar Closed Loop Intraoperative StudyCompletedNCT03270657Not applicableResults posted
• Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral RopiniroleTerminatedNCT03250117Phase 1/2Results posted
• Nintendo WII and Exercises at Rehabilitation of Individuals With Parkinson's DiseaseCompletedNCT03235284Not applicableResults posted
• Parkinson Disease and DBS: Cognitive Effects in GBA Mutation CarriersCompletedNCT03234478Results posted
• rTMS for the Treatment of Freezing of Gait in Parkinson's DiseaseCompletedNCT03219892Not applicableResults posted
• Neuroplasticity in Parkinson´s Disease After TrainingCompletedNCT03213873Not applicableResults posted
• Nilotinib in Parkinson's DiseaseCompletedNCT03205488Phase 2Results posted
• Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's DiseaseCompletedNCT03204526Not applicableResults posted
• BEN-2001 in Parkinson Disease Patients With Excessive Daytime SleepinessCompletedNCT03194217Phase 2Results posted
• Physiological Flow of Liquids Used in Dysphagia Management (Neuro)CompletedNCT03192358Results posted
• Bracing for Walking in Parkinson's DiseaseCompletedNCT03192046Not applicableResults posted
• Safety and Efficacy of DA-9805 for Parkinson's DiseaseCompletedNCT03189563Phase 2Results posted
• A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" EpisodesCompletedNCT03187301Phase 2Results posted
• Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor FluctuationsTerminatedNCT03185481Phase 2Results posted
• Physical Therapy and Deep Brain Stimulation in Parkinson DiseaseCompletedNCT03181282Not applicableResults posted
• Neural and Kinematic Features of Freezing of Gait for Adaptive NeurostimulationCompletedNCT03180515Not applicableResults posted
• Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson DiseaseCompletedNCT03149809Phase 3Results posted
• Cortical Stimulation to Treat Mood and Behavioral Symptoms in Parkinson's Disease PatientsCompletedNCT03131817Not applicableResults posted
• Norepinephrine-targeted Therapy for Action Control in Parkinson DiseaseCompletedNCT03115827Phase 4Results posted
• Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease?TerminatedNCT03104725Phase 1Results posted
• Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms ManagementCompletedNCT03103919Phase 4Results posted
• A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's DiseaseActive, not recruitingNCT03100149Phase 2Results posted
• Modafinil for Freezing of Gait (FOG) in Parkinson's Disease (PD)CompletedNCT03083132Phase 2Results posted
• Ubiquinol in Parkinson's Disease: Safety, Tolerability, and Effects Upon Oxidative Damage and Mitochondrial BiomarkersCompletedNCT03061513Phase 2Results posted
• Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.TerminatedNCT03051607Phase 3Results posted
• Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related ConstipationCompletedNCT03047629Phase 1/2Results posted
• Closed Loop Programming Evaluation Using External Responses for Deep Brain StimulationCompletedNCT03037398Not applicableResults posted
• A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive SleepinessCompletedNCT03037203Phase 2Results posted
• Phase I, KM-819 in Healthy Subjects for Parkinson's DiseaseCompletedNCT03022799Phase 1Results posted
• A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's DiseaseCompletedNCT03007888Phase 2Results posted
• A Study to Evaluate SAGE-217 in Participants With Parkinson's DiseaseCompletedNCT03000569Phase 2Results posted
• Clinical Evaluation of the Infinity Deep Brain Stimulation SystemCompletedNCT02989610Results posted
• A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease PsychosisCompletedNCT02969369Phase 2Results posted
• The Stanford Parkinson's Disease Plasma StudyCompletedNCT02968433Phase 1Results posted
• IPG Replacement Study (PREFERENCE-H)CompletedNCT02963259Results posted
• Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's DiseaseCompletedNCT02954978Phase 2Results posted
• Safety and Efficacy of Liraglutide in Parkinson's DiseaseCompletedNCT02953665Phase 2Results posted
• Evaluation of Intensive Language TherapyCompletedNCT02935842Not applicableResults posted
• Vibrotactile Stimulation in Parkinson's DiseaseCompletedNCT02933476Not applicableResults posted
• Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Proj #3CompletedNCT02933372Phase 2Results posted
• Novel Management of Airway Protection in Parkinson's Disease: A Clinical TrialCompletedNCT02927691Phase 2Results posted
• Cognitive Training in Parkinson StudyCompletedNCT02920632Not applicableResults posted
• The Therapeutic Effect of Transcranial Direct Current Stimulation on Depression in Parkinson's DiseaseTerminatedNCT02917122Phase 1/2Results posted
• Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With DementiaCompletedNCT02910102Phase 2Results posted
• A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene MutationTerminatedNCT02906020Phase 2Results posted
• Telephone-linked Home-based Exercise Training in PDCompletedNCT02898740Not applicableResults posted
• Effect of Simultaneous Dual Stimulation on Freezing of Gait in Parkinson's DiseaseCompletedNCT02850159Not applicableResults posted
• Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the DiseaseTerminatedNCT02847650Phase 2Results posted
• Study to Characterize Acute and Chronic Directional Aspects of Deep Brain StimulationCompletedNCT02835274Not applicableResults posted
• e-Mobile Tablet for People With Chronic ConditionsCompletedNCT02833311Not applicableResults posted
• OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFOCompletedNCT02819011Phase 2Results posted
• A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's DiseaseCompletedNCT02818777Phase 2Results posted
• Buspirone in Parkinson's DiseaseCompletedNCT02803749Phase 2Results posted
• A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)CompletedNCT02799381Phase 3Results posted
• Image Parkinson's Disease Progression StudyCompletedNCT02789020Phase 2Results posted
• A Pilot Study of Suvorexant for Insomnia in Parkinson DiseaseCompletedNCT02729714Phase 4Results posted
• Study of Parkinson's Early Stage With DeferiproneCompletedNCT02728843Phase 2Results posted
• Effectiveness and Implementation of the HiBalance Program in Clinical PracticeCompletedNCT02727478Not applicableResults posted
• A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's DiseaseActive, not recruitingNCT02726386Phase 2Results posted
• Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)CompletedNCT02708186Phase 2Results posted
• TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)CompletedNCT02705755Phase 2Results posted
• Video Based Mindfulness Based Stress ReductionCompletedNCT02705586Not applicableResults posted
• Vestibular Stimulation in Parkinson's DiseaseCompletedNCT02703844Not applicableResults posted
• Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy BodiesCompletedNCT02702102Phase 2Results posted
• Effects of Combined rTMS and Treadmill Training in People With Parkinson's DiseaseCompletedNCT02701647Not applicableResults posted
• Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor FluctuationsTerminatedNCT02687542Phase 2Results posted
• An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease PatientsCompletedNCT02649608Phase 1Results posted
• Study of Urate Elevation in Parkinson's Disease, Phase 3CompletedNCT02642393Phase 3Results posted
• Visual Function During Gait in Parkinson's Disease: Impact of Cognition and Response to Visual CuesCompletedNCT02610634Results posted
• Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's DiseaseCompletedNCT02610231Phase 3Results posted
• Effect of Exercise in ParkinsonismCompletedNCT02598973Not applicableResults posted
• A Clinical Study of Efficacy, Safety, Tolerability and PK of ND0612H in Subjects With Advanced Parkinson's DiseaseCompletedNCT02577523Phase 2Results posted
• PF-06669571 In Subjects With Idiopathic Parkinson's DiseaseCompletedNCT02565628Phase 1Results posted
• Long-term Effect of Low Frequency Stimulation on Aspiration and Freezing of Gait in PD With STN DBSCompletedNCT02549859Not applicableResults posted
• Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®TerminatedNCT02549573Phase 4Results posted
• A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)CompletedNCT02549092Phase 3Results posted
• Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's DiseaseCompletedNCT02542696Phase 3Results posted
• The Effects of Dual Task Training in Individuals With Parkinson's DiseaseCompletedNCT02538029Not applicableResults posted
• Mirabegron in Parkinson Disease and Impaired CognitionCompletedNCT02536976Phase 4Results posted
• Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?CompletedNCT02533921Not applicableResults posted
• Telehealth Cognitive Behavioral Therapy for Depression in Parkinson's Disease (PD)CompletedNCT02475954Not applicableResults posted
• Real-PD Trial: Development of Clinical Prognostic Models for Parkinson's DiseaseCompletedNCT02474329Results posted
• Treating Bacterial Overgrowth in Parkinson's DiseaseCompletedNCT02470780Phase 2/3Results posted
• Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's DiseaseCompletedNCT02469090Phase 3Results posted
• Cognitive Dysfunction In Parkinson'sCompletedNCT02468804Not applicableResults posted
• Safety and Biomarker Study of PTC-589 in Participants With Parkinson's DiseaseCompletedNCT02462603Phase 2Results posted
• Motor Training in PDCompletedNCT02457832Not applicableResults posted
• Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's PatientsTerminatedNCT02453386Phase 3Results posted
• A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD PatientsCompletedNCT02448914Phase 1Results posted
• Physiological Effects of Nutritional Support in Patients With Parkinson's DiseaseCompletedNCT02445651Not applicableResults posted
• Investigation of the Efficacy and Safety of IncobotulinumtoxinA (Xeomin) in Parkinson's Tremor: A Customized ApproachCompletedNCT02419313Phase 2Results posted
• Electronic-health Application To Measure Outcomes REmotely Clinical TrialCompletedNCT02418546Not applicableResults posted
• Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's DiseaseTerminatedNCT02401308Not applicableResults posted
• Adaptive Closed Loop Neuromodulation and Neural Signatures of Parkinson's DiseaseCompletedNCT02384421Not applicableResults posted
• Prism Adaptation Treatment of Parkinson's DiseaseCompletedNCT02380859Not applicableResults posted
• Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational TreatmentTerminatedNCT02365870Phase 4Results posted
• BradyXplore Phase II: Bradykinesia Feature Extraction SystemCompletedNCT02358876Results posted

← Parkinson Disease overview